Powered by

Powered by Portfolio Grader

Alexion Pharmaceuticals (ALXN)

127.55 2.29 (1.76%) 18:30 EST
ALXN Stock Quote Delayed 15 Minutes
  • ALXN Stock Chart

  • Historical ALXN Prices

 
Dividend & Yield:       N/A (N/A)
P/E:       54.74
Market Cap:       28.38B
EPS:       2.33
Volume:       1.02M
Day's Range:       126.30 - 130.09
52wk Range:       92.56 - 140.77
Quotes delayed at least 20 mins.
Historical Data for ALXN
Date Open High Low Volume Close Change %
02/21/19 129.63 130.09 126.30 1,013,556 127.55 -2.29   -1.76%
02/20/19 128.51 130.41 128.45 1,758,158 129.84 0.91   0.71%
02/19/19 128.48 129.78 128.05 1,169,679 128.93 -0.49   -0.38%
02/15/19 125.43 129.49 125.43 1,299,900 129.42 3.49   2.77%
02/14/19 124.73 126.23 123.94 1,017,026 125.93 0.75   0.60%
02/13/19 125.00 125.30 123.21 1,160,431 125.18 0.92   0.74%
02/12/19 121.70 124.37 121.43 1,701,834 124.26 4.21   3.51%
02/11/19 120.76 121.40 119.29 958,415 120.05 -0.09   -0.07%
02/08/19 118.03 120.19 117.80 1,057,600 120.14 1.35   1.14%
02/07/19 119.57 120.37 117.31 1,479,412 118.79 -2.24   -1.85%
02/06/19 122.72 123.10 120.94 1,556,451 121.03 -1.84   -1.50%
02/05/19 123.39 124.88 121.56 1,879,496 122.87 -0.88   -0.71%
02/04/19 128.67 129.00 121.43 3,626,977 123.75 -2.53   -2.00%
02/01/19 124.44 126.51 123.15 2,470,300 126.28 3.32   2.70%
01/31/19 121.41 123.21 120.44 1,663,497 122.96 1.64   1.35%
01/30/19 119.62 121.64 117.66 1,427,926 121.32 1.71   1.43%
01/29/19 119.32 119.99 117.12 2,276,032 119.61 0.40   0.34%
01/28/19 119.87 120.00 117.00 2,011,987 119.21 -2.23   -1.84%
01/25/19 118.98 121.59 118.37 1,501,600 121.44 3.53   2.99%
01/24/19 117.25 117.98 116.38 1,557,372 117.91 0.91   0.78%
01/23/19 115.14 117.98 114.83 2,480,219 117.00 2.71   2.37%
01/22/19 115.28 115.32 112.14 2,841,642 114.29 -2.76   -2.36%
01/18/19 115.70 117.37 113.54 2,528,300 117.05 2.43   2.12%
01/17/19 111.62 115.65 111.10 1,866,805 114.62 2.92   2.61%
01/16/19 111.89 113.99 110.81 2,138,161 111.70 -0.03   -0.03%
01/15/19 108.17 111.77 107.76 1,947,350 111.73 4.15   3.86%
01/14/19 110.02 110.33 107.53 1,654,490 107.58 -3.55   -3.19%
01/11/19 110.68 111.53 108.75 1,339,500 111.13 0.20   0.18%
01/10/19 109.15 111.49 108.45 1,467,699 110.93 0.97   0.88%
01/09/19 108.99 110.74 108.32 1,553,240 109.96 1.35   1.24%
01/08/19 108.65 110.49 105.20 1,701,078 108.61 0.67   0.62%
01/07/19 105.65 108.98 104.70 1,918,693 107.94 1.94   1.83%
01/04/19 101.88 107.30 101.80 2,349,900 106.00 5.79   5.78%
01/03/19 100.15 103.88 99.12 3,274,598 100.21 2.16   2.20%
01/02/19 95.84 99.05 95.16 1,359,467 98.05 0.69   0.71%
12/31/18 98.06 99.81 96.39 1,310,300 97.36 0.15   0.15%
12/28/18 98.52 99.27 96.57 1,407,200 97.21 -0.89   -0.91%
12/27/18 95.83 98.19 93.79 1,466,702 98.10 0.23   0.24%
12/26/18 94.95 97.87 94.04 1,945,172 97.87 3.93   4.18%
12/24/18 93.23 96.57 92.56 1,774,800 93.94 -0.69   -0.73%
12/21/18 101.19 102.37 93.67 5,336,700 94.63 -6.59   -6.51%
12/20/18 102.07 105.02 99.75 2,895,254 101.22 -1.56   -1.52%
12/19/18 106.39 107.72 100.93 2,526,727 102.78 -3.21   -3.03%
12/18/18 110.13 110.74 105.41 1,982,244 105.99 -3.54   -3.23%
12/17/18 109.36 114.07 108.21 2,128,576 109.53 0.10   0.09%
12/14/18 111.59 112.24 108.86 2,120,800 109.43 -3.00   -2.67%
12/13/18 117.27 118.26 112.33 2,470,146 112.43 -4.58   -3.91%
12/12/18 117.24 118.76 116.00 1,391,577 117.01 2.18   1.90%
12/11/18 115.96 117.11 113.28 1,381,546 114.83 0.18   0.16%
12/10/18 115.65 115.99 111.75 1,670,698 114.65 -0.95   -0.82%
12/07/18 119.83 120.98 114.40 1,229,600 115.60 -5.44   -4.49%
12/06/18 120.63 121.15 116.51 1,588,218 121.04 -1.26   -1.03%
12/04/18 125.66 129.36 122.00 1,914,100 122.30 -3.17   -2.53%
Alexion Pharmaceuticals (ALXN) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Alexion Pharmaceuticals Stock Analysis

Rating: Hold

Total Grade: C

Analysis Breakdown

ALXN Stock Grade: C
Fundamental Grade: C
Quantitative Grade: C
ALXN Earnings
Earnings Growth: F
Earnings Momentum: A
Earnings Surprises: B
Analyst Earnings Revisions: A
ALXN Financial Information
Sales Growth: B
Operating Margin Growth: F
Cash Flow: D
Return on Equity: D

Alexion Pharmaceuticals Stock: Weekly View

This Week: C
Last Week: B
Two Weeks Ago: B
Get Full Report